Free Trial

Guggenheim Capital LLC Trims Stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Guggenheim Capital LLC lessened its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 50.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,374 shares of the company's stock after selling 7,439 shares during the quarter. Guggenheim Capital LLC's holdings in Ryan Specialty were worth $473,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Rakuten Securities Inc. bought a new stake in shares of Ryan Specialty during the 4th quarter valued at about $27,000. Principal Securities Inc. boosted its position in Ryan Specialty by 164.7% during the 4th quarter. Principal Securities Inc. now owns 667 shares of the company's stock valued at $43,000 after acquiring an additional 415 shares in the last quarter. Mizuho Bank Ltd. purchased a new position in shares of Ryan Specialty during the 4th quarter worth approximately $49,000. Headlands Technologies LLC raised its position in shares of Ryan Specialty by 2,644.8% in the 4th quarter. Headlands Technologies LLC now owns 796 shares of the company's stock worth $51,000 after acquiring an additional 767 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Ryan Specialty in the 4th quarter valued at approximately $54,000. Institutional investors own 84.82% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on RYAN shares. Keefe, Bruyette & Woods reduced their price target on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Wells Fargo & Company cut their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. UBS Group increased their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. TD Cowen initiated coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 price target for the company. Finally, Barclays dropped their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, Ryan Specialty currently has a consensus rating of "Hold" and a consensus price target of $75.67.

View Our Latest Report on Ryan Specialty

Insider Transactions at Ryan Specialty

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 11.10% of the company's stock.

Ryan Specialty Stock Performance

NYSE RYAN traded up $1.37 on Friday, reaching $66.18. 474,217 shares of the stock were exchanged, compared to its average volume of 1,058,430. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a one year low of $48.85 and a one year high of $77.16. The firm has a market capitalization of $17.33 billion, a PE ratio of 95.96, a PEG ratio of 1.19 and a beta of 0.66. The company's 50-day simple moving average is $70.21 and its two-hundred day simple moving average is $68.77.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.39 earnings per share for the quarter, hitting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million during the quarter, compared to analyst estimates of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business's quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.35 earnings per share. Analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were paid a $0.12 dividend. The ex-dividend date was Tuesday, March 4th. This represents a $0.48 annualized dividend and a dividend yield of 0.73%. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. Ryan Specialty's dividend payout ratio is currently 69.57%.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Featured Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines